Published in Exp Biol Med (Maywood) on May 08, 2009
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation. Transfusion (2011) 0.90
Placenta as a newly identified source of hematopoietic stem cells. Curr Opin Hematol (2010) 0.82
Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling. Dev Cell (2012) 0.82
Conditioned umbilical cord tissue provides a natural three-dimensional storage compartment as in vitro stem cell niche for human mesenchymal stroma/stem cells. Stem Cell Res Ther (2016) 0.76
Human term placenta a new abundant source of hematopoietic cells--a potent alternative for cord blood and bone marrow. Exp Biol Med (Maywood) (2009) 0.75
Comparative Analysis of the Hematopoietic Progenitor Cells from Placenta, Cord Blood, and Fetal Liver, Based on Their Immunophenotype. Biomed Res Int (2015) 0.75
The human chorion contains definitive hematopoietic stem cells from the fifteenth week of gestation. Development (2017) 0.75
Hematopoietic stem-cell transplantation. N Engl J Med (2006) 10.45
Definitive hematopoiesis is autonomously initiated by the AGM region. Cell (1996) 5.75
The placenta is a niche for hematopoietic stem cells. Dev Cell (2005) 3.83
Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers. Antimicrob Agents Chemother (2000) 3.28
Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. EMBO J (2000) 3.10
The murine placenta contains hematopoietic stem cells within the vascular labyrinth region. Dev Cell (2005) 2.91
The journey of developing hematopoietic stem cells. Development (2006) 2.71
Lymphoid potential, probed before circulation in mouse, is restricted to caudal intraembryonic splanchnopleura. Cell (1996) 2.60
Complete reconstitution of human lymphocytes from cord blood CD34+ cells using the NOD/SCID/gammacnull mice model. Blood (2003) 2.53
The hare and the tortoise: an embryonic haematopoietic race. Nat Rev Immunol (2002) 2.08
Double umbilical cord blood transplantation. Curr Opin Immunol (2006) 1.81
AMD3100 mobilizes hematopoietic stem cells with long-term repopulating capacity in nonhuman primates. Blood (2006) 1.79
Expanding the role of umbilical cord blood transplantation. Br J Haematol (2007) 1.67
New trends in umbilical cord blood transplantation. Blood (2005) 1.56
Mouse placenta is a major hematopoietic organ. Development (2003) 1.54
Murine embryonic B lymphocyte development in the placenta. Nature (1979) 1.20
Collection, processing and cryopreservation of umbilical cord blood for unrelated transplantation. Bone Marrow Transplant (2000) 1.15
Placenta as a site for hematopoietic stem cell development. Exp Hematol (2005) 1.11
Effects of the ventilation pattern and pulmonary blood flow on lung heat transfer. Eur J Appl Physiol (2003) 1.03
Hematopoietic repopulating ability of cord blood CD34(+) cells in NOD/Shi-scid mice. Stem Cells (2000) 0.97
A new role for the human placenta as a hematopoietic site throughout gestation. Reprod Sci (2009) 0.97
Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease? Am J Respir Crit Care Med (2003) 2.93
VEGF modulates erythropoiesis through regulation of adult hepatic erythropoietin synthesis. Nat Med (2006) 2.67
Mammalian long-chain acyl-CoA synthetases. Exp Biol Med (Maywood) (2008) 2.28
Revised nomenclature for the mammalian long-chain acyl-CoA synthetase gene family. J Lipid Res (2004) 2.08
Decreased arginine bioavailability and increased serum arginase activity in asthma. Am J Respir Crit Care Med (2004) 2.01
Tropomodulin 1-null mice have a mild spherocytic elliptocytosis with appearance of tropomodulin 3 in red blood cells and disruption of the membrane skeleton. Blood (2010) 1.99
Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. Br J Haematol (2007) 1.84
Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood (2002) 1.83
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia. Biol Blood Marrow Transplant (2003) 1.81
Outcome of patients with hemoglobinopathies given either cord blood or bone marrow transplantation from an HLA-identical sibling. Blood (2013) 1.68
Comparison of protocols for measuring and calculating postmortem submersion intervals for human analogs in fresh water. J Forensic Sci (2012) 1.38
Hemolysis-associated pulmonary hypertension in thalassemia. Ann N Y Acad Sci (2005) 1.35
Mammalian acyl-CoA:lysophosphatidylcholine acyltransferase enzymes. Proc Natl Acad Sci U S A (2007) 1.33
Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state. Am J Hematol (2006) 1.31
Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. Biol Blood Marrow Transplant (2011) 1.24
β-globin gene transfer to human bone marrow for sickle cell disease. J Clin Invest (2013) 1.22
Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transplant (2012) 1.21
HLA-matched sibling bone marrow transplantation for β-thalassemia major. Blood (2010) 1.20
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease. Blood (2007) 1.17
Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer (2009) 1.15
Hydroxyurea and arginine therapy: impact on nitric oxide production in sickle cell disease. J Pediatr Hematol Oncol (2003) 1.14
Imaging of the diffusion of single band 3 molecules on normal and mutant erythrocytes. Blood (2009) 1.12
Activity of the acyl-CoA synthetase ACSL6 isoforms: role of the fatty acid Gate-domains. BMC Biochem (2010) 1.08
Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol Biol (2006) 1.06
Hydrolysis of phosphatidylserine-exposing red blood cells by secretory phospholipase A2 generates lysophosphatidic acid and results in vascular dysfunction. J Biol Chem (2005) 1.06
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. Br J Haematol (2006) 1.04
A pilot study of the short-term use of simvastatin in sickle cell disease: effects on markers of vascular dysfunction. Br J Haematol (2011) 1.02
SLC5A8 gene, a transporter of butyrate: a gut flora metabolite, is frequently methylated in African American colon adenomas. PLoS One (2011) 1.00
Compromised mitochondrial fatty acid synthesis in transgenic mice results in defective protein lipoylation and energy disequilibrium. PLoS One (2012) 1.00
Sildenafil therapy in thalassemia patients with Doppler-defined risk of pulmonary hypertension. Haematologica (2013) 0.99
In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica (2004) 0.98
The effects of disruption of genes for peroxiredoxin-2, glutathione peroxidase-1, and catalase on erythrocyte oxidative metabolism. Free Radic Biol Med (2009) 0.96
Identification of an erythroid ATP-dependent aminophospholipid transporter. Br J Haematol (2006) 0.95
Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies. Semin Hematol (2010) 0.94
Quality of long-term cryopreserved umbilical cord blood units for hematopoietic cell transplantation. Int J Hematol (2011) 0.93
Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia. Biol Blood Marrow Transplant (2009) 0.93
Clinical hemoglobinopathies: iron, lungs and new blood. Curr Opin Hematol (2006) 0.92
Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease. Br J Haematol (2011) 0.92
Fetal haemoglobin augmentation in E/beta(0) thalassaemia: clinical and haematological outcome. Br J Haematol (2005) 0.92
Multipotent stromal stem cells from human placenta demonstrate high therapeutic potential. Stem Cells Transl Med (2012) 0.92
A 29-kDa protein associated with p67phox expresses both peroxiredoxin and phospholipase A2 activity and enhances superoxide anion production by a cell-free system of NADPH oxidase activity. J Biol Chem (2002) 0.91
Hematopoietic cell transplantation for nonmalignant disorders. Biol Blood Marrow Transplant (2012) 0.91
Large-scale arrays of picolitre chambers for single-cell analysis of large cell populations. Lab Chip (2010) 0.91
Reactive oxygen species and phosphatidylserine externalization in murine sickle red cells. Br J Haematol (2004) 0.90
A simple assay for frequency of chromosome breaks and loss (micronuclei) by flow cytometry of human reticulocytes. FASEB J (2004) 0.89
Protein kinase C activation induces phosphatidylserine exposure on red blood cells. Biochemistry (2002) 0.89
Selective increase of autoimmune epitope expression on aged erythrocytes in mice: implications in anti-erythrocyte autoimmune responses. J Autoimmun (2002) 0.88
Altered red cell turnover in diabetic mice. J Lab Clin Med (2002) 0.88
A pilot study of subcutaneous decitabine in β-thalassemia intermedia. Blood (2011) 0.88
Stem-cell transplantation for sickle cell disease. N Engl J Med (2010) 0.87
Transfusional iron burden and liver toxicity after bone marrow transplantation for acute myelogenous leukemia and hemoglobinopathies. Pediatr Blood Cancer (2008) 0.85
Treatment of hepatitis C virus infection in thalassemia. Ann N Y Acad Sci (2005) 0.85
ATP8A1 activity and phosphatidylserine transbilayer movement. J Receptor Ligand Channel Res (2008) 0.85
Phosphatidylcholine formation by LPCAT1 is regulated by Ca(2+) and the redox status of the cell. BMC Biochem (2012) 0.84
SEL1L, an UPR response protein, a potential marker of colonic cell transformation. Dig Dis Sci (2012) 0.84
A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes. Haematologica (2013) 0.84
Secretory phospholipase A2 levels in patients with sickle cell disease and acute chest syndrome. Hemoglobin (2006) 0.84
Characterization of an acyl-coenzyme A binding protein predominantly expressed in human primitive progenitor cells. J Lipid Res (2008) 0.84
Recent advances in bone marrow transplantation in hemoglobinopathies. Curr Mol Med (2008) 0.83
Evaluation of the Spectra Optia apheresis system for mononuclear cell (MNC) collection in G-CSF mobilized and nonmobilized healthy donors: results of a multicenter study. J Clin Apher (2014) 0.82
Inability to maintain GSH pool in G6PD-deficient red cells causes futile AMPK activation and irreversible metabolic disturbance. Antioxid Redox Signal (2015) 0.82
Measuring chromosome breaks in patients with thalassemia. Ann N Y Acad Sci (2005) 0.81
Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S. Am J Physiol Cell Physiol (2011) 0.81
Cord blood transplantation for sickle cell anemia: bust or boom? Pediatr Transplant (2007) 0.80
Remodeling of host phosphatidylcholine by Chlamydia acyltransferase is regulated by acyl-CoA binding protein ACBD6 associated with lipid droplets. Microbiologyopen (2015) 0.80
Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment. Ann N Y Acad Sci (2005) 0.80
Eukaryotic protein recruitment into the Chlamydia inclusion: implications for survival and growth. PLoS One (2012) 0.80
Hybrid InGaAsP-InP Mach-Zehnder Racetrack Resonator for Thermooptic Switching and Coupling Control. Opt Express (2005) 0.80
Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296. Int J Hematol (2002) 0.80
Elevated tricuspid regurgitant jet velocity in subgroups of thalassemia patients: insight into pathophysiology and the effect of splenectomy. Ann Hematol (2014) 0.79
Postinjury serum secretory phospholipase A2 correlates with hypoxemia and clinical status at 72 hours. J Am Coll Surg (2005) 0.79
Sulphydryl modifications alter scramblase activity in murine sickle cell disease. Br J Haematol (2006) 0.79
Improved engraftment with minimal graft-versus-host disease after major histocompatibility complex-mismatched cord blood transplantation with photochemically treated donor lymphocytes. Exp Biol Med (Maywood) (2011) 0.78
Rescued mice with Hb E transgene-developed red cell changes similar to human beta-thalassemia/HbE disease. Ann N Y Acad Sci (2005) 0.78
Flow cytometric determination of PMCA-mediated Ca2+-extrusion in individual red blood cells. Cytometry A (2007) 0.78
Serum C-reactive protein parallels secretory phospholipase A2 in sickle cell disease patients with vasoocclusive crisis or acute chest syndrome. Blood (2005) 0.78
Comprehensive banking of sibling donor cord blood for children with malignant and nonmalignant disease. Blood (2002) 0.78
Fatal hepatic sinusoidal obstruction syndrome in a child with primary CNS lymphoma during induction therapy. Int J Hematol (2012) 0.77
Combined umbilical cord blood and bone marrow from HLA-identical sibling donors for hematopoietic stem cell transplantation in children with hemoglobinopathies. Pediatr Blood Cancer (2014) 0.77
A transgenic mouse model expressing exclusively human hemoglobin E: indications of a mild oxidative stress. Blood Cells Mol Dis (2012) 0.77
Gene therapy and bone marrow transplantation for thalassemia: changing of the guard? Mol Ther (2010) 0.77
Secretory phospholipase A2: a marker of infection in febrile children presenting to a pediatric ED. Am J Emerg Med (2010) 0.76
Successful treatment of hepatic sinusoidal obstructive syndrome after hematopoietic stem cell transplantation in a child using recombinant thrombomodulin. Acta Haematol (2012) 0.76
Extensive peritoneal carcinomatosis secondary to renal cell carcinoma with sarcomatoid and rhabdoid differentiation. BMJ Case Rep (2013) 0.76
Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells. Am J Hematol (2008) 0.76
Stem cell transplantation with S-59 photochemically treated T-cell add-backs to establish allochimerism in murine thalassemia. Ann N Y Acad Sci (2005) 0.76
Microparticles as biomarkers of osteonecrosis of the hip in sickle cell disease. Br J Haematol (2014) 0.76
Umbilical cord blood transplantation for thalassemia major. Hematol Oncol Clin North Am (2010) 0.76
Research in athletes with sickle cell trait: just do it. J Appl Physiol (1985) (2012) 0.75